Search by Drug Name or NDC

NDC 43063-0870-10 Ondansetron 8 mg/1 Details

Ondansetron 8 mg/1

Ondansetron is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is ONDANSETRON.

MedlinePlus Drug Summary

Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.

Related Packages: 43063-0870-10
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Ondansetron

Product Information

NDC	43063-0870
Product ID	43063-870_f9296a5a-0cd6-92d0-e053-6294a90acee9
Associated GPIs	50250065007240
GCN Sequence Number	041563
GCN Sequence Number Description	ondansetron TAB RAPDIS 8 MG ORAL
HIC3	H6J
HIC3 Description	ANTIEMETIC/ANTIVERTIGO AGENTS
GCN	20046
HICL Sequence Number	019058
HICL Sequence Number Description	ONDANSETRON
Brand/Generic	Generic
Proprietary Name	Ondansetron
Proprietary Name Suffix	n/a
Non-Proprietary Name	Ondansetron
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, ORALLY DISINTEGRATING
Route	ORAL
Active Ingredient Strength	8
Active Ingredient Units	mg/1
Substance Name	ONDANSETRON
Labeler Name	PD-Rx Pharmaceuticals, Inc.
Pharmaceutical Class	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA090469
Listing Certified Through	2024-12-31

Package

NDC 43063-0870-10 (43063087010)

Pricing Information	N/A
NDC Package Code	43063-870-10
Billing NDC	43063087010
Package	10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-870-10)
Marketing Start Date	2018-07-26
NDC Exclude Flag	N